Nutriband Inc is a biotechnology company focused on the development and commercialization of innovative transdermal drug delivery systems and other advanced technologies for the pharmaceutical and healthcare industries
By leveraging cutting-edge research and proprietary platforms, the company aims to enhance the efficacy and safety of medications, providing solutions that improve patient compliance and therapeutic outcomes. Their product pipeline includes a range of applications, from pain management to the treatment of various medical conditions, reflecting their commitment to advancing healthcare through technology.
In this video, I review the market warnings I've shared over the past three weeks and how Friday's session confirmed negative divergences across key metrics signaling weakness.
Shares of Kodiak Sciences Inc. (NASDAQKOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.
Shares of LuxUrban Hotels Inc. (NASDAQLUXH) fell sharply during Wednesday’s session after the company issued preliminary fourth-quarter revenue outlook below estimates.
Gainers PainReform Ltd. (NASDAQPRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement.
